Addus HomeCare (NASDAQ:ADUS) Releases Quarterly Earnings Results, Misses Estimates By $0.09 EPS

Addus HomeCare (NASDAQ:ADUS) posted its earnings results on Monday. The company reported $1.26 EPS for the quarter, missing the consensus estimate of $1.35 by ($0.09), Zacks reports. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%.

Addus HomeCare Price Performance

Shares of NASDAQ ADUS traded down $0.39 during midday trading on Monday, hitting $108.84. The stock had a trading volume of 387,696 shares, compared to its average volume of 171,008. Addus HomeCare has a fifty-two week low of $85.94 and a fifty-two week high of $136.72. The firm has a market cap of $1.97 billion, a P/E ratio of 24.91, a price-to-earnings-growth ratio of 1.45 and a beta of 1.00. The company’s 50-day simple moving average is $125.04 and its 200 day simple moving average is $126.80.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the company. StockNews.com upgraded Addus HomeCare from a “hold” rating to a “buy” rating in a research report on Friday, January 24th. Macquarie restated an “outperform” rating and set a $139.00 target price on shares of Addus HomeCare in a research report on Monday, November 4th. Oppenheimer raised their target price on Addus HomeCare from $145.00 to $150.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. Royal Bank of Canada restated an “outperform” rating and set a $136.00 target price on shares of Addus HomeCare in a research report on Thursday, November 14th. Finally, JMP Securities started coverage on Addus HomeCare in a research report on Monday, December 16th. They issued an “outperform” rating and a $150.00 price objective for the company. One equities research analyst has rated the stock with a sell rating, eight have assigned a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, Addus HomeCare has an average rating of “Buy” and an average price target of $134.22.

Insider Buying and Selling at Addus HomeCare

In other Addus HomeCare news, EVP Roberton James Stevenson sold 2,250 shares of the business’s stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $121.00, for a total value of $272,250.00. Following the completion of the transaction, the executive vice president now directly owns 10,217 shares of the company’s stock, valued at approximately $1,236,257. The trade was a 18.05 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO R Dirk Allison sold 25,000 shares of the business’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $124.76, for a total value of $3,119,000.00. Following the completion of the transaction, the chief executive officer now directly owns 79,397 shares of the company’s stock, valued at approximately $9,905,569.72. The trade was a 23.95 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 4.60% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.